Radius Health (RDUS) Tops Q3 EPS by 19c, Revenues Beat; Offers FY18 Revenue Views Above Consensus, Offers FY19 Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to Radius Health (RDUS) Tops Q3 EPS by 19c, Revenues Beat; Offers FY18 Revenue Views Above Consensus, Offers FY19 Revenue Outlook

Radius Health Announces Third Quarter 2018 Operating Results and Financial Guidance for FY 2018 and FY 2019

November 1, 2018 7:40 AM EDT

TYMLOS® U.S. net sales continued to increase in the third quarter of 2018, totaling $27.6 million.2019 Medicare Part D coverage for TYMLOS increased from 44% to 64% 

Elacestrant Phase 3 study to target a broader patient population, comprised of 2nd and 3rd line ER+ mBC, with potential for success in the overall and biomarker-selected populations. Initiation expected in the fourth quarter of 2018

Full-year TYMLOS net revenues expected to be $95m to $98m for 2018 and $155m to $175m for 2019. Year-end cash, cash equivalents and investments anticipated to exceed $220m for 2018 and $100m for... More